Preeclampsia and HELLP Syndrome NCLEX Case Study: Full Clinical Reasoning Walk-Through

Preeclampsia with severe features and HELLP syndrome is one of the highest-yield obstetric emergencies tested on the NCLEX. It appears in stand-alone questions, unfolding case studies, and Next Generation NCLEX formats including bow-tie and matrix items. The reason it is tested so heavily is simple: this condition kills mothers and babies when nurses fail to recognize it, and the clinical reasoning required to manage it maps perfectly onto every layer of the NCSBN's Clinical Judgment Measurement Model (CJMM). In this walk-through, you will work through an original patient scenario from initial presentation to postpartum recovery. Every clinical decision point is explained with the specific numbers, thresholds, and rationale you need for the exam. This is not a textbook summary. This is bedside reasoning, step by step, the way you will need to think when you sit for the NCLEX and when you are the nurse in the room.

The Clinical Scenario

This scenario contains at least 15 abnormal findings. Your job is to find every single one, connect them to the underlying pathophysiology, and act on them in the correct priority order. That is exactly what the NCLEX expects from you. Let's begin.

Step 1: Recognize Cues — What Findings Are Clinically Significant?

The first layer of the CJMM asks: what information in the scenario is relevant? Not everything in a patient chart matters equally. On the NCLEX, you will be given a large amount of data and expected to identify which findings signal a problem. Here is every significant cue in Maria's case and why it matters.

Severe-Range Hypertension

Maria's blood pressure is 174/110, confirmed at 168/108 fifteen minutes later. According to ACOG (American College of Obstetricians and Gynecologists), severe-range hypertension is defined as systolic blood pressure of 160 mmHg or greater OR diastolic blood pressure of 110 mmHg or greater, confirmed on repeat measurement within 15 minutes. Maria meets both criteria. This is not gestational hypertension. This is not mild preeclampsia. This is a hypertensive emergency in pregnancy that requires treatment within 30 to 60 minutes of confirmation to prevent stroke.

Central Nervous System Warning Signs

Maria has a persistent headache unresponsive to acetaminophen and new-onset visual disturbances ("floaters"). These are not incidental complaints. In the context of preeclampsia, these symptoms represent cerebral vasospasm and retinal arteriolar spasm, respectively. They are considered warning signs for impending eclamptic seizure. On the NCLEX, any pregnant patient after 20 weeks with a headache that does not resolve with analgesics plus visual changes should immediately raise your suspicion for preeclampsia with severe features.

Right Upper Quadrant Pain

RUQ pain in preeclampsia is caused by hepatic capsule distention from edema and microhemorrhages within the liver parenchyma. This is an ominous finding because it indicates liver involvement and places the patient at risk for hepatic rupture — a rare but catastrophic complication. RUQ pain is listed as a severe feature of preeclampsia in ACOG criteria and is often the presenting symptom that distinguishes HELLP syndrome from preeclampsia without hepatic involvement.

Hyperreflexia with Clonus

DTRs of 4+ with sustained clonus indicate heightened central nervous system irritability. Normal DTRs in pregnancy are 2+. Hyperreflexia alone is a concerning finding. Clonus — involuntary rhythmic contractions elicited by dorsiflexion of the foot — is a late sign of CNS hyperexcitability and further supports the risk for eclamptic seizure. The NCLEX expects you to assess and document DTRs as part of any preeclampsia workup and to recognize that clonus elevates the urgency of seizure prophylaxis.

The HELLP Triad

Maria's labs paint a clear picture of HELLP syndrome — Hemolysis, Elevated Liver enzymes, Low Platelets:

• ✅ Hemolysis: Schistocytes on peripheral smear (fragmented red blood cells), LDH 740 (more than double the upper limit of normal), dropping hemoglobin
• ✅ Elevated Liver enzymes: AST 156 and ALT 178, both more than three times the upper limit of normal
• ✅ Low Platelets: 72,000/mm³, dropped from 198,000 in just 5 weeks

Significant Proteinuria

A 24-hour urine protein of 5.2 grams is massively elevated (normal is less than 300 mg in pregnancy). The dipstick reading of 4+ supports this. However, here is a critical point that the NCLEX tests directly:

Reassuring Fetal Status

The fetal heart rate tracing is Category I — normal baseline, moderate variability, accelerations present, no decelerations. A biophysical profile of 8/8 is reassuring. This finding is clinically significant not because it raises alarm, but because it directly influences the delivery timing decision. A reassuring fetal status in the context of HELLP at 33 weeks may allow a brief window (24 to 48 hours) for corticosteroid administration for fetal lung maturity, whereas a non-reassuring tracing would mandate immediate delivery.

Step 2: Analyze Cues — Connecting Findings to Pathophysiology

Now that you have identified every significant finding, the next CJMM layer asks: what do these findings mean together? This is where you demonstrate that you understand the disease, not just the data points.

The Underlying Mechanism: Endothelial Dysfunction

Preeclampsia is fundamentally a disease of abnormal placentation leading to widespread maternal endothelial dysfunction. In normal pregnancy, the trophoblast cells remodel the spiral arteries to create a high-flow, low-resistance blood supply to the placenta. In preeclampsia, this remodeling fails. The under-perfused placenta releases anti-angiogenic factors (such as soluble fms-like tyrosine kinase 1, or sFlt-1) into the maternal circulation. These factors damage the endothelium throughout the body, leading to vasospasm, increased vascular permeability, and activation of the coagulation cascade.

Every organ system finding in Maria's case traces back to this single mechanism:

• Brain: Cerebral vasospasm → headache, visual disturbances, hyperreflexia, seizure risk
• Liver: Hepatic sinusoidal obstruction and periportal necrosis → elevated AST/ALT, RUQ pain, risk of capsular rupture
• Kidneys: Glomerular endotheliosis → proteinuria, rising creatinine (0.6 → 1.3 mg/dL)
• Blood: Microangiopathic hemolytic anemia → schistocytes, falling hemoglobin, elevated LDH
• Platelets: Consumption in damaged microvasculature → thrombocytopenia (198K → 72K)
• Vasculature: Widespread vasospasm → severe hypertension

HELLP as a Severe Variant

HELLP syndrome is not a separate disease from preeclampsia — it is a severe variant characterized by microangiopathic hemolysis. The Tennessee Classification System categorizes HELLP by platelet nadir:

• Class I (most severe): Platelets <50,000/mm³
• Class II: Platelets 50,000–100,000/mm³
• Class III (partial HELLP): Platelets 100,000–150,000/mm³

Maria currently has Class II HELLP with platelets at 72,000. But the trajectory is critical: she dropped from 198,000 to 72,000 in approximately 5 weeks — a loss of 126,000 platelets. If this rate of consumption continues, she could reach Class I (<50,000) within days. This trajectory, not just the current number, drives the urgency of delivery planning.

Renal Involvement

Maria's creatinine has risen from 0.6 to 1.3 mg/dL. In non-pregnant adults, 1.3 might look borderline. But in pregnancy, the GFR increases by 50%, making the normal creatinine range 0.4 to 0.8 mg/dL. A creatinine of 1.3 in a pregnant patient represents significant renal impairment. This finding is also directly relevant to magnesium sulfate management: magnesium is renally cleared, so reduced renal function increases the risk of magnesium toxicity. The nurse must monitor urine output meticulously.

Why Proteinuria Alone Does Not Define Preeclampsia

Before 2013, preeclampsia was defined as hypertension plus proteinuria. ACOG revised the diagnostic criteria because research showed that some of the most dangerous preeclampsia cases — including those progressing to eclampsia — presented with minimal or no proteinuria. The current definition requires new-onset hypertension after 20 weeks plus either proteinuria OR at least one severe feature. Maria has proteinuria AND multiple severe features, making the diagnosis unambiguous. But on the NCLEX, you may encounter a patient with a BP of 162/105, platelet count of 88,000, and a negative urine dipstick. That patient still has preeclampsia with severe features.

Step 3: Prioritize Hypotheses — What Is the Most Urgent Problem?

Maria has multiple critical problems simultaneously: severe hypertension, risk of eclamptic seizure, HELLP syndrome with declining platelets, renal impairment, and a preterm fetus. On the NCLEX, you must identify the single highest priority. This is where students frequently lose points.

The priority is seizure prevention. Here is why.

An eclamptic seizure in a patient with Maria's profile — severe hypertension, CNS symptoms (headache, visual disturbances), hyperreflexia with clonus, and a platelet count of 72,000 — carries a high risk of maternal death. The seizure itself can cause aspiration, placental abruption, and fetal hypoxia. In a patient with low platelets, a seizure also increases the risk of intracranial hemorrhage because the impaired coagulation system cannot contain bleeding from damaged cerebral vessels. Additionally, the uncontrolled hypertension means cerebral autoregulation may already be overwhelmed; a seizure on top of this can trigger hemorrhagic stroke.

ACOG Severe Features Checklist

For the NCLEX, you should be able to identify all of the criteria that classify preeclampsia as having "severe features." Maria meets five of them:

• ✅ Systolic BP ≥160 mmHg or diastolic BP ≥110 mmHg on two occasions at least 4 hours apart (or severe enough to warrant antihypertensive therapy before 4 hours)
• ✅ Thrombocytopenia (platelets <100,000/mm³)
• ✅ Liver transaminases elevated to twice the upper limit of normal
• ✅ Renal insufficiency (creatinine >1.1 mg/dL or doubling in absence of other renal disease)
• ✅ Cerebral or visual disturbances
• ❌ Pulmonary edema (not present in Maria's case — yet)

Meeting even ONE of these criteria, in addition to new-onset hypertension after 20 weeks, qualifies as preeclampsia with severe features. Maria meets five. The clinical picture is unambiguous, and delay is dangerous.

Step 4: Generate Solutions — Immediate Management

This is where the NCLEX tests whether you know what to DO. The following interventions should be initiated in rapid sequence — ideally within the first 30 to 60 minutes of presentation.

1. Magnesium Sulfate for Seizure Prophylaxis

Magnesium sulfate is the gold-standard medication for prevention and treatment of eclamptic seizures. It works by stabilizing neuronal membranes and reducing CNS excitability through calcium channel blockade at the neuromuscular junction.

• Loading dose: 4 to 6 grams IV over 15 to 20 minutes (typically given as 4g IV bolus diluted in 100 mL normal saline via infusion pump)
• Maintenance dose: 1 to 2 g/hour continuous IV infusion
• Therapeutic serum level: 4 to 7 mEq/L (4.8 to 8.4 mg/dL)

2. Antihypertensive Therapy

The goal is to reduce blood pressure to below 160/110 mmHg to prevent hemorrhagic stroke, without dropping it so rapidly that uteroplacental perfusion is compromised. ACOG-recommended first-line agents include:

• IV Labetalol: Initial dose 20 mg IV push over 2 minutes, may escalate to 40 mg then 80 mg at 10-minute intervals (maximum 300 mg cumulative). Combined alpha- and beta-blocker.
• IV Hydralazine: 5 to 10 mg IV push every 20 minutes (maximum 20 mg). Direct arterial vasodilator. Monitor for reflex tachycardia.
• Oral Nifedipine: 10 to 20 mg PO, may repeat in 30 minutes. Calcium channel blocker. Used when IV access is being established or as step-down therapy.

Target: Reduce BP to 140-150/90-100 mmHg range. Do NOT aim for normotension — the fetus depends on adequate placental perfusion, and overshooting the target can cause fetal distress.

3. Betamethasone for Fetal Lung Maturity

At 33 weeks gestation, Maria is within the window for antenatal corticosteroid administration (24 to 33+6 weeks per ACOG, with consideration up to 36+6 weeks for those at risk of preterm delivery within 7 days who have not received a prior course). Betamethasone 12 mg IM is given as two doses, 24 hours apart. This accelerates fetal surfactant production and significantly reduces the incidence and severity of neonatal respiratory distress syndrome, intraventricular hemorrhage, and necrotizing enterocolitis.

The question at Maria's gestational age is: can we delay delivery 24 to 48 hours to complete the steroid course? The answer depends on maternal and fetal stability, which is reassessed continuously.

4. Concurrent Stabilization Measures

• Two large-bore IV access sites — anticipate potential surgical delivery and possible hemorrhage
• Foley catheter for strict intake and output monitoring (urine output is a critical magnesium safety parameter)
• Continuous fetal monitoring — any change in fetal status may accelerate the delivery timeline
• Labs repeated every 6 hours: CBC with platelet count, comprehensive metabolic panel (AST, ALT, creatinine, LDH) to track HELLP progression or stabilization
• Type and screen — have blood products available given thrombocytopenia and risk of hemorrhage
• Seizure precautions: bed in low position, side rails padded, suction at bedside, oxygen and ambu bag at bedside, dim lighting, minimize stimulation
• Anesthesia consultation early — platelet count affects regional anesthesia options

Step 5: Take Action — Magnesium Sulfate Monitoring (The Core NCLEX Skill)

Magnesium sulfate monitoring is one of the most frequently tested nursing skills on the NCLEX for OB content. The drug has a narrow therapeutic window, and the nurse's assessment is the primary safety mechanism. If you learn nothing else from this case study, learn this section. For a deeper review of OB nursing priorities, see our comprehensive OB/Maternity NCLEX guide.

The Four Assessments You Must Perform Hourly

1. Deep Tendon Reflexes (DTRs)

Loss of patellar reflexes is the earliest clinical sign of magnesium toxicity. It occurs at serum levels of 8 to 10 mEq/L (the therapeutic range is 4 to 7). Check patellar reflexes bilaterally every hour. If reflexes are absent, STOP the magnesium infusion immediately and notify the provider. Do not wait for a serum level — absent reflexes are your signal to act.

2. Respiratory Rate

Respiratory depression occurs at serum magnesium levels of 10 to 13 mEq/L. Assess respiratory rate every hour (or more frequently if the patient is symptomatic). Hold the infusion if the respiratory rate falls below 12 breaths per minute. Magnesium-induced respiratory failure is the most common cause of magnesium-related maternal death.

3. Urine Output

Magnesium is cleared exclusively by the kidneys. If urine output drops below 30 mL/hour, magnesium accumulates and toxicity risk rises sharply. This is especially important in Maria's case because her creatinine is already elevated at 1.3 mg/dL, indicating impaired renal clearance. The Foley catheter allows continuous monitoring. If urine output falls below 30 mL/hour for 2 consecutive hours, the infusion rate must be reduced or held and the provider notified.

4. Level of Consciousness

Magnesium is a CNS depressant. Normal therapeutic effects include a feeling of warmth and mild drowsiness. Excessive sedation, confusion, or difficulty arousing the patient suggests toxicity. Assess orientation and responsiveness hourly.

Magnesium Toxicity Progression

Understanding the dose-response relationship of magnesium toxicity allows you to anticipate and intervene at the earliest stage:

• 4–7 mEq/L: Therapeutic range — flushing, warmth, mild nausea, decreased DTRs (from hyperactive toward normal)
• 8–10 mEq/L: Loss of deep tendon reflexes — FIRST clinical sign of toxicity → STOP infusion
• 10–13 mEq/L: Respiratory depression, significant muscle weakness, somnolence → STOP infusion, prepare antidote
• >15 mEq/L: Cardiac arrest (heart block, asystole) → code emergency

The Antidote: Calcium Gluconate

Calcium gluconate 1 gram (10 mL of 10% solution) IV push over 3 minutes must be kept at the bedside at all times during magnesium administration. It directly antagonizes magnesium at the neuromuscular junction and cardiac conduction system. Do not confuse calcium gluconate with calcium chloride — calcium chloride is more concentrated and caustic and is reserved for cardiac arrest protocols, not for magnesium antidote use.

Duration of Magnesium Therapy

Magnesium sulfate is continued for 24 hours after delivery — not 24 hours after initiation. The postpartum period carries significant seizure risk because the endothelial dysfunction does not resolve immediately upon delivery. The 24-hour postpartum window is the standard of care and is a high-yield NCLEX test point.

The Delivery Decision at 33 Weeks with HELLP

Maria is at 33 weeks with confirmed HELLP syndrome. The definitive treatment for preeclampsia is delivery. But at 33 weeks, the fetus benefits significantly from antenatal corticosteroids. Here is the decision framework:

• If the maternal condition stabilizes on magnesium and antihypertensives AND fetal status remains reassuring → administer first dose of betamethasone and plan delivery in 24-48 hours
• If HELLP progresses (platelets falling, liver enzymes rising, DIC developing) OR fetal status becomes non-reassuring → deliver immediately regardless of steroid completion
• At 34 weeks or beyond with HELLP → delivery is indicated without delay for steroid completion per ACOG guidelines

In Maria's case, with reassuring fetal status and Class II HELLP that is currently stable on treatment, the team may attempt a 24-48 hour window for steroid benefit while monitoring labs every 6 hours. However, any deterioration triggers immediate delivery. The nurse's role is to recognize deterioration — rising liver enzymes, falling platelets, new symptoms — and escalate immediately.

Step 6: Evaluate Outcomes — Postpartum Monitoring

One of the most important — and most commonly missed — NCLEX concepts in preeclampsia is that delivery does not immediately cure the disease. The postpartum period is a high-risk window that demands vigilant nursing assessment. This section covers what the NCLEX expects you to know about postpartum preeclampsia management.

Postpartum Eclampsia Is Real

Approximately 30% of eclamptic seizures occur postpartum. They can happen up to 6 weeks after delivery, though most occur within the first 48 hours. This is why magnesium sulfate is continued for 24 hours after delivery, and why postpartum patients with a history of preeclampsia must be monitored for new or worsening symptoms. Any new severe headache, visual changes, or epigastric/RUQ pain in the postpartum period requires urgent evaluation — even if the patient has already been "treated" for preeclampsia.

Hemodynamic Shifts After Delivery

After delivery, large volumes of fluid shift from the extravascular space back into the intravascular compartment. In a patient with preeclampsia — who already has endothelial damage and increased vascular permeability — this fluid shift can precipitate pulmonary edema. Assess breath sounds every 2 to 4 hours postpartum. Monitor for dyspnea, orthopnea, cough with frothy sputum, and oxygen desaturation. Strict intake and output monitoring continues. Excessive IV fluid administration during this period significantly increases pulmonary edema risk.

Postpartum Hemorrhage Risk

Maria faces an elevated risk of postpartum hemorrhage for two reasons. First, magnesium sulfate is a smooth muscle relaxant — it acts on the uterus the same way it acts on blood vessels, reducing uterine tone and potentially causing atony. The nurse must assess fundal tone frequently and be prepared to administer uterotonic agents (oxytocin, methylergonovine, carboprost) if the uterus becomes boggy. Second, her thrombocytopenia (platelets 72,000) impairs clot formation, meaning even normal postpartum bleeding may become uncontrolled. Platelet transfusion is typically considered if the platelet count falls below 50,000 with active bleeding or below 20,000 without bleeding.

Lab Trends to Monitor

HELLP syndrome labs follow a predictable pattern after delivery:

• Platelets: Typically reach their nadir (lowest point) at 24 to 48 hours postpartum, then begin to recover. If platelets have not started rising by 72 hours postpartum, consider alternative diagnoses (TTP, HUS, or ongoing DIC).
• Liver enzymes (AST, ALT): Peak at 24 to 48 hours postpartum, then gradually decline. Resolution typically takes 3 to 5 days. Persistent elevation beyond this suggests ongoing hepatic injury.
• LDH: Follows a similar pattern to liver enzymes; trends down as hemolysis resolves.
• Creatinine: Should begin to decrease as renal perfusion improves. Persistent elevation warrants nephrology consultation.

Neurological Monitoring

New or worsening neurological symptoms in the postpartum period after preeclampsia require urgent imaging. Posterior reversible encephalopathy syndrome (PRES) is an underrecognized complication characterized by headache, visual disturbances, altered consciousness, and seizures. It is caused by vasogenic edema predominantly in the posterior cerebral circulation. Hemorrhagic stroke is another devastating complication that can present as sudden severe headache, focal neurological deficits, or rapid decline in consciousness. The nurse should perform neurological checks (orientation, pupil response, motor strength, speech) every 1 to 2 hours in the immediate postpartum period.

Epidural Considerations

If Maria requires cesarean delivery, anesthesia options depend on her platelet count. General guidelines (these vary by institution):

• Platelets ≥70,000–80,000: Neuraxial anesthesia (epidural or spinal) is generally considered safe, though anesthesia will weigh the risk-benefit individually.
• Platelets 50,000–70,000: Decision is individualized. Many anesthesiologists will proceed with spinal anesthesia (lower risk than epidural) if the platelet count is stable and coagulation studies are normal.
• Platelets <50,000: General anesthesia is typically required. Neuraxial anesthesia is contraindicated due to risk of spinal/epidural hematoma.

Maria's platelets at 72,000 are borderline. Anesthesia consult should be obtained early so the team can plan. If platelets are falling and delivery is likely, early epidural placement while the count is still adequate may be the safest strategy.

The Delivery Decision Matrix

The NCLEX may present you with scenarios at different gestational ages and ask when delivery is appropriate. Here is the evidence-based framework based on ACOG guidelines:

Gestational Age and Timing of Delivery

• <24 weeks with severe features or HELLP: Delivery indicated (previable or periviable counseling; expectant management rarely attempted)
• 24–33+6 weeks with severe features, stable: Corticosteroids and delivery after 48 hours if maternal/fetal condition allows. Continuous monitoring required.
• 24–33+6 weeks with HELLP or unstable severe features: Deliver after corticosteroid administration if possible, but do not delay delivery beyond 24-48 hours for steroid completion if the condition is deteriorating.
• ≥34 weeks with severe features or HELLP: Deliver. Do not delay for steroids at this gestational age per ACOG — the risks of continuing pregnancy outweigh the benefits.
• ≥37 weeks with preeclampsia without severe features: Deliver. Expectant management past 37 weeks provides no benefit.

Vaginal Versus Cesarean Delivery

HELLP syndrome and preeclampsia with severe features are NOT automatic indications for cesarean delivery. The route of delivery depends on standard obstetric factors: cervical favorability, gestational age, fetal presentation, and fetal status. Induction of labor with vaginal delivery is preferred when the cervix is favorable and there are no obstetric contraindications. Cesarean is reserved for standard indications (non-reassuring fetal status, failed induction, malpresentation) or when rapid delivery is needed and induction would take too long.

Long-Term Implications

Preeclampsia is not just a pregnancy complication — it is a cardiovascular risk marker for life. Women who have had preeclampsia have approximately double the lifetime risk of developing chronic hypertension, coronary artery disease, stroke, and heart failure. The more severe the preeclampsia and the earlier the onset, the greater the long-term risk.

Nursing responsibilities extend beyond the acute episode:

• Postpartum follow-up: Blood pressure monitoring at 72 hours and again at 7-10 days postpartum. Some patients require antihypertensive medication for weeks to months after delivery.
• Future pregnancy counseling: The recurrence risk for preeclampsia in a subsequent pregnancy is approximately 15-20% after a single episode, higher if the first episode was severe or early-onset. Low-dose aspirin (81 mg daily starting at 12 weeks gestation) is recommended for prophylaxis in subsequent pregnancies for patients with a history of preeclampsia.
• Lifetime cardiovascular screening: Annual blood pressure monitoring, lipid panels, and glucose screening are recommended. The American Heart Association recognizes preeclampsia as a risk factor for cardiovascular disease.

On the NCLEX, discharge teaching questions may ask about follow-up appointments, warning signs to report, and long-term health implications. The correct answers reflect the understanding that preeclampsia has consequences that extend far beyond the postpartum period.

How the NCLEX Tests This

Preeclampsia and HELLP syndrome appear across multiple NGN question formats. Understanding how each format tests this content helps you anticipate what you will face on exam day.

Select All That Apply (SATA) / Extended Multiple Response

Common stem: "Which findings indicate the patient is developing preeclampsia with severe features?" You will be given 8-10 options mixing severe features (correct) with non-severe or unrelated findings (incorrect). You need to select every severe feature without including findings that are normal in pregnancy (such as mild ankle edema or Braxton-Hicks contractions).

Cloze (Drop-Down) Questions

These fill-in-the-blank questions test specific values: "The nurse should hold magnesium sulfate if the respiratory rate is below ___ breaths per minute" (answer: 12). Or: "The nurse should ensure ___ is at the bedside before initiating magnesium sulfate" (answer: calcium gluconate). Precision matters — the NCLEX wants the exact threshold, not a range.

Matrix/Grid Questions

A matrix may present multiple medications (magnesium sulfate, labetalol, hydralazine, betamethasone, lisinopril) and ask you to mark which are "indicated," "contraindicated," or "not applicable" for a pregnant patient with preeclampsia. Your knowledge must be precise enough to classify each medication correctly.

Traditional Multiple Choice — Priority Questions

The classic question: "Which intervention should the nurse implement FIRST?" When all four options are reasonable nursing actions (assess BP, start magnesium, check fetal heart tones, draw labs), you must apply clinical judgment frameworks to identify the highest priority. In an acute presentation with CNS symptoms and clonus, seizure prophylaxis with magnesium is the first action.

For practice with these question types, try our free NCLEX practice questions or explore the full case study library for more unfolding clinical scenarios.

Key Takeaways

1. Severe-range hypertension = SBP ≥160 OR DBP ≥110. Either value alone qualifies. Confirmed on two readings within 15 minutes. Treat within 30-60 minutes to prevent stroke.
2. Proteinuria is NOT required to diagnose preeclampsia. Since the 2013 ACOG update, new-onset hypertension after 20 weeks plus any severe feature establishes the diagnosis.
3. Magnesium sulfate prevents seizures — it does NOT lower blood pressure. Separate antihypertensive agents (labetalol, hydralazine, nifedipine) must be given concurrently for severe-range BP.
4. Magnesium safety monitoring = DTRs + respiratory rate + urine output. Loss of reflexes is the first sign of toxicity. Hold for RR <12 or UO <30 mL/hr. Calcium gluconate at the bedside is mandatory.
5. HELLP = Hemolysis (schistocytes, elevated LDH) + Elevated Liver enzymes + Low Platelets. Track the platelet trajectory, not just the current number. Tennessee Classification: Class I (<50K), Class II (50-100K), Class III (100-150K).
6. Delivery is the definitive treatment, but it does not immediately cure the disease. Continue magnesium for 24 hours postpartum. Monitor for postpartum eclampsia, pulmonary edema, and hemorrhage.
7. Postpartum eclampsia can occur up to 6 weeks after delivery. Any new headache, visual changes, or elevated BP in a recently postpartum patient demands urgent evaluation with seizure precautions.
8. ACE inhibitors and ARBs are absolutely contraindicated in pregnancy. Any "-pril" or "-sartan" option is wrong for a pregnant patient. No exceptions.
9. HELLP syndrome is NOT an automatic indication for cesarean. Delivery route depends on standard obstetric factors: cervical status, fetal presentation, and fetal condition.
10. Preeclampsia doubles lifetime cardiovascular risk. Discharge teaching includes long-term follow-up, aspirin prophylaxis in future pregnancies (81 mg starting at 12 weeks), and annual cardiovascular screening.

Frequently Asked Questions

What is the difference between preeclampsia and HELLP syndrome?

Preeclampsia is a hypertensive disorder of pregnancy defined by new-onset hypertension after 20 weeks gestation with proteinuria or other end-organ damage. HELLP syndrome is a severe variant of preeclampsia specifically characterized by hemolytic anemia (fragmented red blood cells and elevated LDH), elevated liver enzymes (AST and ALT), and low platelet count. Not all patients with preeclampsia develop HELLP, and approximately 15-20% of HELLP cases present without significant hypertension or proteinuria, which can delay diagnosis. HELLP carries higher maternal morbidity and mortality than preeclampsia without HELLP.

Why is magnesium sulfate given instead of an antihypertensive for seizure prevention?

Eclamptic seizures are not caused by the elevated blood pressure itself. They result from cerebral vasospasm, endothelial dysfunction, and blood-brain barrier disruption. Magnesium sulfate stabilizes neuronal cell membranes and blocks excessive calcium influx at the neuromuscular junction, directly preventing the seizure mechanism. Clinical trials (notably the Magpie Trial) demonstrated that magnesium sulfate reduces eclampsia risk by 58% — no antihypertensive has shown this effect. Antihypertensive medications lower blood pressure to prevent stroke but do not address the seizure pathway. Both medications are needed simultaneously in severe preeclampsia, but they serve different purposes.

What is the antidote for magnesium sulfate toxicity?

Calcium gluconate, 1 gram (10 mL of 10% solution) administered IV push over 3 minutes, is the antidote for magnesium toxicity. It works by directly antagonizing magnesium at the neuromuscular junction and cardiac conduction system. It must be kept at the bedside throughout magnesium administration. It does not lower the magnesium serum level — it counteracts its effects while the body clears the excess magnesium through the kidneys. Do not confuse calcium gluconate with calcium chloride, which is a more concentrated formulation used primarily in cardiac arrest protocols.

Can preeclampsia develop after delivery?

Yes. Postpartum preeclampsia and postpartum eclampsia are well-documented conditions. Most cases occur within 48 hours of delivery, but they can develop up to 6 weeks postpartum, even in patients who had no hypertensive disorder during pregnancy. Symptoms include severe headache, visual disturbances, upper abdominal pain, nausea/vomiting, and significantly elevated blood pressure. Treatment is the same as antepartum management: magnesium sulfate for seizure prophylaxis and antihypertensive therapy for severe-range blood pressure. Any woman presenting with these symptoms in the postpartum period should be evaluated urgently.

What platelet count is needed for epidural anesthesia?

There is no universally agreed-upon absolute threshold, but most anesthesiologists consider neuraxial anesthesia (epidural or spinal) safe when the platelet count is ≥70,000-80,000/mm³ and the count is stable or rising. Between 50,000 and 70,000, the decision is individualized — some providers will proceed with spinal anesthesia (lower risk of hematoma than epidural) if coagulation studies are otherwise normal. Below 50,000, neuraxial anesthesia is generally contraindicated due to the risk of epidural or spinal hematoma, and general anesthesia is planned. The trend of the platelet count matters as much as the absolute number — a rapidly falling count suggests ongoing consumption and higher procedural risk.

When should delivery occur with HELLP syndrome?

At 34 weeks or beyond, delivery should occur promptly after diagnosis of HELLP syndrome regardless of symptom severity. Between 24 and 33+6 weeks, the decision depends on maternal and fetal stability: if both are stable, delivery may be delayed 24-48 hours to administer corticosteroids for fetal lung maturity, with continuous maternal and fetal monitoring and serial labs every 6 hours. If the condition is deteriorating — worsening labs, DIC, non-reassuring fetal status, or maternal symptoms — delivery proceeds immediately regardless of gestational age or steroid completion. The only definitive treatment for HELLP is delivery of the placenta.

Want to assess your overall NCLEX readiness? Try our NCLEX Readiness Predictor to see where you stand across all content areas, or explore our full question bank for comprehensive exam preparation.